Shareholder meetings, this week and ahead.
Every upcoming AGM and special meeting at a rated U.S. public issuer. Record dates, nomination deadlines, board grades, and non-standard ballot items shown inline. Defaults to the next 14 days; expand the window from the filter bar.
Browse all upcoming meetings by month
Wednesday, July 15, 2026
1 meeting| Company | Performance | Ballot summary |
|---|---|---|
| FERMI INCContested | Board: C- 1Y TSR: — | Shareholder proponents led by Toby R. Neugebauer are seeking to call a special meeting to (1) repeal board-adopted bylaw amendments, (2) allow shareholders to set board size and increase it by seven seats, (3) ensure shareholders can nominate at special meetings, (4) elect seven nominees (or three replacements), and (5) remove three incumbent directors for cause, enabling a new board majority to pursue a strategic review including potential sale or partnership. |
Thursday, July 16, 2026
1 meeting| Company | Performance | Ballot summary |
|---|---|---|
| ADVANCED DRAINAGE SYSTEMS INC | Board: B 1Y TSR: +25.2% | Election of nine directors; Ratification of Deloitte & Touche LLP as independent auditors for fiscal 2027; Advisory (non-binding) vote to approve named executive officer compensation. |
Tuesday, July 21, 2026
1 meeting| Company | Performance | Ballot summary |
|---|---|---|
| GENESCO INCContested | Board: C 1Y TSR: +52.9% | Election of nine directors (including two shareholder nominees), a non-binding advisory 'Say on Pay' vote on executive compensation, approval of an amended equity incentive plan increasing the share reserve, and ratification of Deloitte as the company’s independent registered public accounting firm. |
Wednesday, July 22, 2026
3 meetings| Company | Performance | Ballot summary |
|---|---|---|
| CONSTELLATION BRANDS INC | Board: C- 1Y TSR: -16.1% | Elect twelve directors; ratify the selection of KPMG LLP as independent registered public accounting firm; approve, on an advisory basis, the compensation of the Company’s named executive officers; approve the amendment and restatement of the Company’s Long‑Term Stock Incentive Plan; and transact any other properly presented business. |
| MCKESSON CORP | Board: B 1Y TSR: +9.4% | Elect 11 director nominees; Ratify Deloitte & Touche LLP as independent auditor for FY2027; Advisory (non-binding) vote on executive compensation (say-on-pay). |
| SAMSARA INC | Board: C+ 1Y TSR: -13.3% | Elect eight directors; ratify Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending January 30, 2027; and approve, on a non-binding advisory basis, the compensation of the company’s named executive officers. |
Thursday, July 23, 2026
2 meetings| Company | Performance | Ballot summary |
|---|---|---|
| BROWN FORMAN CORP | Board: C- 1Y TSR: -5.3% | Stockholders will vote to elect eleven directors, approve on a non-binding advisory basis the compensation of the company’s named executive officers (say-on-pay), and ratify Ernst & Young LLP as the independent registered public accounting firm for fiscal 2027. |
| JAZZ PHARMACEUTICALS PLC | Board: B- 1Y TSR: +107.1% | Election of three directors; Ratification and remuneration authorization for KPMG as auditor; Non-binding advisory vote on executive compensation (say-on-pay); Approval to grant the board authority to allot and issue ordinary shares; Special resolution to allow board to allot and issue ordinary shares for cash without offering to existing shareholders (pre-emption opt-out) up to ~20% of issued share capital for 18 months; Adjournment proposal to solicit additional proxies if insufficient votes for Proposals 4 or 5. |